Challenges and Opportunities in Gene Delivery - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 75

[59] Torchilin V, Levchenko T, Rammohan R, Volodina N, Papahadjopoulos-Sternberg B,
D'Souza G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-
DNA complexes. Proc Natl Acad Sci USA 2003;100:1972-7.
[60] Narang AS, Thoma L, Miller DD, Mahato RI. Cationic lipids with increased DNA bind-
ing affinity for nonviral gene transfer in dividing and nondividing Cells. Bioconjugate
Chem 2005;16:156-68.
[61] Ruponen M, Yla-Herttuala S, Urtti A. Interactions of polymeric and liposomal gene
delivery systems with extracellular glycosaminoglycans: physicochemical and transfec-
tion studies. Biochim Biophys Acta 1999;1415:331-41.
[62] Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN. Improved
DNA: liposome complexes for increased systemic delivery and gene expression. Nat
Biotechnol 1997;15:647-52.
[63] Crook K, Stevenson BJ, Dubouchet M, Porteous DJ. Inclusion of cholesterol in DOTAP
transfection complexes increases the delivery of DNA to cells in vitro in the presence of
serum. Gene Ther 1998;5:137-43.
[64] Sakurai F, Nishioka T, Yamashita F, Takakura Y, Hashida M. Effects of erythrocytes and serum
proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid
in the single-pass rat lung perfusion system. Eur J Pharm Biopharm 2001;52:165-72.
[65] Koltover I, Salditt T, Safinya CR. Phase diagram, stability, and overcharging of lamellar
cationic lipid-DNA self-assembled complexes. Biophys J 1999;77:915-24.
[66] Mao S, Neu M, Germershaus O, Merkel O, Sitterberg J, Bakowsky U, et al. Influence
of polyethylene glycol chain length on the physicochemical and biological properties of
poly (ethylene imine)- graft -poly (ethylene glycol) block copolymer/siRNA polyplexes.
Bioconjugate Chem 2006;17:1209-18.
[67] Li W, Huang Z, MacKay JA, Grube S, Szoka FC. Low-pH-sensitive poly(ethylene
glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid
composition and assembly conditions on gene delivery. J Gene Med 2005;7:67-79.
[68] Hong K, Zheng W, Baker A, Papahadjopoulos D. Stabilization of cationic liposome-
plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conju-
gates for efficient in vivo gene delivery. FEBS Lett 1997;400:233-37.
[69] Choi YH, Liu F, Kim JS, Choi YK, Park JS, Kim SW. Polyethylene glycol-grafted poly-
L-lysine as polymeric gene carrier. J Control Release 1998;54:39-48.
[70] Oupicky D, Howard KA, Konak C, Dash PR, Ulbrich K, Seymour LW. Steric stabiliza-
tion of poly-L-lysine/DNA complexes by the covalent attachment of semitelechelic poly
( N -(2-hydroxypropyl) methacrylamide). Bioconjugate Chem 2000;11:492-501.
[71] Pun SH, Davis ME. Development of a non-viral gene delivery vehicle for systemic appli-
cation. Bioconjugate Chem 2002;13:630-9.
[72] Yang Y, Park Y, Man S, Liu Y, Rice KG. Cross-linked low molecular weight glycopeptides
mediated gene delivery: Relationship between DNA metabolic stability and the level of
transient gene expression in vivo . J Pharm Sci 2001;90:2010-22.
[73] Trubetskoy VS, Loomis A, Slattum PM, Hagstrom JE, Budker VG, Wolff JA. Caged
DNA does not aggregate in high ionic strength solutions. Bioconjugate Chem 1999;10:
624-8.
[74] Mumper RJ, Duguid JG, Anwer K, Barron MK, Nitta H, Rolland AP. Polyvinyl deriva-
tives as novel interactive polymers for controlled gene delivery to muscle. Pharm Res
1996;13:701-9.
[75] Huang CY, Ma SS, Lee S, Radhakrishnan R, Braun CS, Choosakoonkriang S, et al.
Enhancements in gene expression by the choice of plasmid DNA formulations contain-
ing neutral polymeric excipients. J Pharm Sci 2002;91:1371-81.